- Home
- HSCS vs CELU Comparison
HSCS vs CELU Comparison
Compare HSCS & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSCS | CELU |
|---|---|---|
| Founded | 2007 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 17.3M |
| IPO Year | 2022 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HSCS | CELU |
|---|---|---|
| Price | $4.73 | $1.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $6.00 |
| AVG Volume (30 Days) | 135.7K | ★ 10.9M |
| Earning Date | 03-16-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.84 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,319.00 | ★ $26,550,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $76.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.63 | $0.56 |
| 52 Week High | $5.25 | $2.55 |
Technical Indicators
Market Signals| Indicator | HSCS | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 66.28 | 55.51 |
| Support Level | $1.88 | $1.10 |
| Resistance Level | N/A | $1.43 |
| Average True Range (ATR) | 0.52 | 0.12 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 74.00 | 44.70 |
Price Performance
Historical ComparisonAbout HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.